Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters

被引:27
作者
Gumurdulu, Derya [1 ]
Erdogan, Seyda
Kayaselcuk, Fazilet
Seydaoglu, Gulsah
Parsak, Cem K.
Demircan, Orhan
Tuncer, Ilhan
机构
[1] Cukurova Univ, Affiliated Hosp, Fac Med, Dept Pathol, TR-01330 Adana, Turkey
[2] Baskent Univ, Affiliated Hosp, Adana Res & Practice Ctr, Dept Pathol, TR-01330 Adana, Turkey
[3] Cukurova Univ, Affiliated Hosp, Fac Med, Dept Biostat, TR-01330 Adana, Turkey
[4] Cukurova Univ, Affiliated Hosp, Fac Med, Dept Surg, TR-01330 Adana, Turkey
关键词
gastrointestinal stromal tumor; cyclooxygenase-2; proliferating cell nuclear antigen; Ki-67; p53; immunohistochemistry;
D O I
10.3748/wjg.v13.i3.426
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the expression of Cyclooxygenase-2 (COX-2), proliferating cell nuclear antigen (PCNA), Ki-67 and p53 in gastrointestinal stromal tumors (GISTs) and its relationship with histopathological parameters. METHODS: Twenty-five GISTs were examined by light microscopy and immunohistochemistry. c-kit, CD34, SMA, S-100 protein, COX-2, PCNA, Ki-67 and p53 were detected immunohistochemically and the relationship was evaluated among histopathologic parameters such as mitotic index (MI), tumor grade, tumor size, COX-2, PCNA, Ki-67 and p53. RESULTS: COX-2 protein expression was found in 19 of 25 (76%) of the tumors, and expression was noted in the cytoplasm of the tumor cells. p53 was significantly related to MI and tumor grade but no relationship was found between COX-2, proliferation markers and MI, tumor grade and tumor size. CONCLUSION: COX-2 is expressed in most GISTs and it may play an important role in the proliferation and progression of these tumors or a useful marker to identify GIST Although immunohistochemical assessment of p53 can be used for distinguishing the risk groups of GISTs, tumor size and mitotic rate should be considered at the same time. (c) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:426 / 431
页数:6
相关论文
共 33 条
  • [21] SANO H, 1995, CANCER RES, V55, P3785
  • [22] SBASCHNIG RJ, 1994, MODERN PATHOL, V7, P780
  • [23] Seidal T, 1999, HISTOPATHOLOGY, V34, P416
  • [24] Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10-/- mice
    Shattuck-Brandt, RL
    Varilek, GW
    Radhika, A
    Yang, FJ
    Washington, MK
    DuBois, RN
    [J]. GASTROENTEROLOGY, 2000, 118 (02) : 337 - 345
  • [25] Cyclooxygenase-2 expression in stromal tumors of the gastrointestinal tract
    Sheehan, KM
    Sabah, M
    Cummins, RJ
    O'Grady, A
    Murray, FE
    Leader, MB
    Kay, EW
    [J]. HUMAN PATHOLOGY, 2003, 34 (12) : 1242 - 1246
  • [26] Gastrointestinal stromal tumor of the stomach: Report of a case
    Shirai, H
    Takeuchi, T
    Naka, T
    Minaghi, S
    Kimura, A
    Hamazaki, S
    Ito, H
    [J]. SURGERY TODAY, 2001, 31 (04) : 346 - 349
  • [27] The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
    Steinbach, G
    Lynch, PM
    Phillips, RKS
    Wallace, MH
    Hawk, E
    Gordon, GB
    Wakabayashi, N
    Saunders, B
    Shen, Y
    Fujimura, T
    Su, LK
    Levin, B
    Godio, L
    Patterson, S
    Rodriguez-Bigas, MA
    Jester, SL
    King, KL
    Schumacher, M
    Abbruzzese, J
    DuBois, RN
    Hittelman, WN
    Zimmerman, S
    Sherman, JW
    Kelloff, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) : 1946 - 1952
  • [28] Cyclooxygenase-2 expression and clinical outcome in gastrointestinal stromal tumors
    Stewart, AE
    Heslin, MH
    Arch, J
    Jhala, N
    Ragland, B
    Gomez, F
    Bland, KI
    Arnoletti, JP
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (02) : 315 - 319
  • [29] Suster S, 1996, SEMIN DIAGN PATHOL, V13, P297
  • [30] THUN MJ, 1993, CANCER RES, V53, P1322